Liu Yuepeng相关文献与解析，生知库 | 链接生命科学的每一步

Li, Mengling; Sun, Erchao; Wang, Shuangshuang; Huang, Yuxuan; Song, Haiguang; Kuang, Sirong; Li, Guoqi; Liu, Yuepeng; Xia, Ziwei; Zhang, Xueqi; Han, Jiumin; Dong, Zhaoxu; Rao, Venigalla B; Sun, Lvhui; Tao, Pan

发表日期：2026

文献求助收藏

Synergistic anticancer effects of cabozantinib and cuproptosis induction driven by DHRS2-KAT2A-H3K27ac axis in clear cell renal cell carcinoma

卡博替尼与DHRS2-KAT2A-H3K27ac轴驱动的铜凋亡诱导在透明细胞肾细胞癌中具有协同抗癌作用

期刊:Biology Direct

影响因子:4.9

doi:10.1186/s13062-025-00721-z

Cao, Yilong; Xu, Chao; Zhang, Bowei; Qu, Changbao; Liu, Yuepeng; Shi, Bei; Li, Xiaoling; Li, Jiehan; Zhang, Zeyuan; Dai, Shengtao; Sun, Qingyun; Wang, Yaxuan; Gu, Junfei

Jujuboside A induces bladder cancer cell apoptosis by inhibiting ATP1A2-mediated mitochondrial energy metabolism regulation.

枣苷A通过抑制ATP1A2介导的线粒体能量代谢调节诱导膀胱癌细胞凋亡。

期刊:Cancer Biology & Therapy

影响因子:4.6

doi:10.1080/15384047.2026.2615418

Zhu Meng, Liu Yuepeng, Jia Yumin, Ren Lixin, An Shuhui, Wang Yaxuan

CCT3-mediated regulation of XPO1/RB1 axis stability promotes cellular senescence and tumor progression in clear cell renal carcinoma.

CCT3介导的XPO1/RB1轴稳定性调控促进透明细胞肾癌的细胞衰老和肿瘤进展。

期刊:iScience

影响因子:4.1

doi:10.1016/j.isci.2026.114840

Cao Yilong, Xu Chao, Liu Yuepeng, Shi Bei, Li Xiaoling, Li Jiehan, Zhang Bowei, Zhang Zeyuan, Dai Shengtao, Sun Qingyun, Gu Junfei

Ectopic FGFR1 Increases Intracellular Pool of Cholesterol in Prostate Cancer Cells

异位表达的FGFR1增加前列腺癌细胞内胆固醇含量

期刊:International Journal of Molecular Sciences

影响因子:0.7

doi:10.3390/ijms27031190.

Ziying Liu,Yuepeng Ke,Tingting Hong,Kennedy Smith,Peter Davies,Yun Huang,Dekai Zhang,Sanjukta Chakraborty,Yubin Zhou,Fen Wang

Augmenting Large Language Model With Prompt Engineering and Supervised Fine-Tuning in Non-Small Cell Lung Cancer Tumor-Node-Metastasis Staging: Framework Development and Validation

利用提示工程和监督微调增强大型语言模型在非小细胞肺癌肿瘤-淋巴结-转移分期中的应用：框架开发与验证

期刊:

影响因子:

doi:10.2196/77988

Jin, Ruonan; Ling, Chao; Hou, Yixuan; Sun, Yuhan; Li, Ning; Han, Jiefei; Sheng, Jin; Wang, Qizhao; Liu, Yuepeng; Zheng, Shen; Ren, Xingyu; Chen, Chiyu; Wang, Jue; Li, Cheng

ERβ/circAHNAK Axis Inhibits USP10-FMR1 Deubiquitination to Prevent m⁶A-Mediated ADAM17 Decay and Promote Angiogenesis in Clear Cell Renal Cell Carcinoma

ERβ/circAHNAK轴抑制USP10-FMR1去泛素化，从而阻止m⁶A介导的ADAM17降解并促进透明细胞肾细胞癌的血管生成

期刊:Advanced Science

影响因子:14.1

doi:10.1002/advs.202509654

Xu, Chao; Zhang, Sujing; Liu, Yuepeng; Lv, Jingwei; Cao, Yilong; Chen, Yao; Sun, Hao; Zhang, Bowei; Dai, Shengtao; Li, Jiehan; Li, Xiaoling; Shi, Bei; Sun, Qingyun; Zhu, Meng; Gu, Junfei

Repurposing salicylic acid as a versatile inducer of proximity

将水杨酸重新用作一种多功能邻近诱导剂

期刊:Nature Chemical Biology

影响因子:12.9

doi:10.1038/s41589-025-01918-z

Tianlu Wang # ，Siyao Liu # ，Yuepeng Ke ，Sher Ali ，Rui Wang ，Tingting Hong ，Ziying Liu ，Guolin Ma ，Tien-Hung Lan ，Fen Wang ，Michael X Zhu ，Yun Huang ，Yubin Zhou

发表日期：2025

文献求助收藏

Machine learning identification of a novel vasculogenic mimicry-related signature and FOXM1's role in promoting vasculogenic mimicry in clear cell renal cell carcinoma

利用机器学习方法鉴定一种新型血管生成拟态相关特征以及FOXM1在促进透明细胞肾细胞癌血管生成拟态中的作用

期刊:Translational Oncology

影响因子:4.1

doi:10.1016/j.tranon.2025.102312

Xu, Chao; Zhang, Sujing; Lv, Jingwei; Cao, Yilong; Chen, Yao; Sun, Hao; Dai, Shengtao; Zhang, Bowei; Zhu, Meng; Liu, Yuepeng; Gu, Junfei

First-Line Tislelizumab Plus Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer: PD-L1 ≥ 50% Subgroup Analysis from the RATIONALE-304 Trial

一线替雷利珠单抗联合化疗治疗晚期非鳞状非小细胞肺癌：RATIONALE-304试验中PD-L1 ≥ 50%亚组分析

期刊:Oncology and Therapy

影响因子:3.2

doi:10.1007/s40487-025-00378-8

Lu, Shun; Wang, Jie; Yu, Yan; Yu, Xinmin; Hu, Yanping; Wangjun, Liao; Li, Xingya; Liu, Yuepeng; Li, Weidong; Qu, Xiaofei; Bao, Yuanyuan; Wang, Mengzhao

Periplasmic gatekeeping of phage DNA entry by an rSAM enzyme matured effector with HxS repeats

具有HxS重复序列的成熟效应蛋白通过rSAM酶对噬菌体DNA进入周质空间进行门控

Synergistic anticancer effects of cabozantinib and cuproptosis induction driven by DHRS2-KAT2A-H3K27ac axis in clear cell renal cell carcinoma

卡博替尼与DHRS2-KAT2A-H3K27ac轴驱动的铜凋亡诱导在透明细胞肾细胞癌中具有协同抗癌作用

Jujuboside A induces bladder cancer cell apoptosis by inhibiting ATP1A2-mediated mitochondrial energy metabolism regulation.

枣苷A通过抑制ATP1A2介导的线粒体能量代谢调节诱导膀胱癌细胞凋亡。

CCT3-mediated regulation of XPO1/RB1 axis stability promotes cellular senescence and tumor progression in clear cell renal carcinoma.

CCT3介导的XPO1/RB1轴稳定性调控促进透明细胞肾癌的细胞衰老和肿瘤进展。

Ectopic FGFR1 Increases Intracellular Pool of Cholesterol in Prostate Cancer Cells

异位表达的FGFR1增加前列腺癌细胞内胆固醇含量

Augmenting Large Language Model With Prompt Engineering and Supervised Fine-Tuning in Non-Small Cell Lung Cancer Tumor-Node-Metastasis Staging: Framework Development and Validation

利用提示工程和监督微调增强大型语言模型在非小细胞肺癌肿瘤-淋巴结-转移分期中的应用：框架开发与验证

ERβ/circAHNAK Axis Inhibits USP10-FMR1 Deubiquitination to Prevent m⁶A-Mediated ADAM17 Decay and Promote Angiogenesis in Clear Cell Renal Cell Carcinoma

ERβ/circAHNAK轴抑制USP10-FMR1去泛素化，从而阻止m⁶A介导的ADAM17降解并促进透明细胞肾细胞癌的血管生成

Repurposing salicylic acid as a versatile inducer of proximity

将水杨酸重新用作一种多功能邻近诱导剂

Machine learning identification of a novel vasculogenic mimicry-related signature and FOXM1's role in promoting vasculogenic mimicry in clear cell renal cell carcinoma

利用机器学习方法鉴定一种新型血管生成拟态相关特征以及FOXM1在促进透明细胞肾细胞癌血管生成拟态中的作用

First-Line Tislelizumab Plus Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer: PD-L1 ≥ 50% Subgroup Analysis from the RATIONALE-304 Trial

一线替雷利珠单抗联合化疗治疗晚期非鳞状非小细胞肺癌：RATIONALE-304试验中PD-L1 ≥ 50%亚组分析